300026 红日药业
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)0.7690.2160.2475.9607.773
总资产报酬率 ROA (%)0.6330.1720.1874.1375.145
投入资产回报率 ROIC (%)0.7170.1970.2144.8146.075

边际利润分析
销售毛利率 (%)57.42958.30952.75854.10957.727
营业利润率 (%)7.4912.1070.6138.00910.715
息税前利润/营业总收入 (%)7.8571.9991.40610.68211.577
净利润/营业总收入 (%)6.0710.4500.3978.2119.342

收益指标分析
经营活动净收益/利润总额(%)116.603381.073358.05585.741102.181
价值变动净收益/利润总额(%)-0.565-4.427-10.429-0.2310.441
营业外收支净额/利润总额(%)-0.463-25.97934.35819.3730.538

偿债能力分析
流动比率 (X)4.7004.4613.7934.2952.758
速动比率 (X)3.6173.3912.7143.0411.931
资产负债率 (%)15.88716.72221.19625.07233.154
带息债务/全部投入资本 (%)4.6664.6848.13414.77420.587
股东权益/带息债务 (%)1,999.3741,989.3221,101.805567.423377.808
股东权益/负债合计 (%)520.919490.082365.251293.538197.508
利息保障倍数 (X)19.5926.1192.97414.27714.383

营运能力分析
应收账款周转天数 (天)188.378183.464167.426179.592186.193
存货周转天数 (天)251.838272.674244.461268.047225.278